Omentin serum levels and omentin gene Val109Asp polymorphism in patients with psoriasis

International Journal of Dermatology

Volumn 53, Issue 5, 2014, Pages 601-605

  Turan, Hakan ^a   Yaykasli, Kursat Oguz ^a   Soguktas, Hatice ^a   Yaykasli, Emine ^a   Aliagaoglu, Cihangir ^a   Erdem, Teoman ^b   Karkucak, Mutlu ^b   Kaya, Ertugrul ^a   Ucgun, Taner ^a   Bahadir, Anzel ^a  

^a DUZCE UNIVERSITY   (Turkey)

^b SAKARYA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; OMENTIN PROTEIN; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSPOT ASSAY; EXON; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PSORIASIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WAIST CIRCUMFERENCE; BLOOD; GENETIC POLYMORPHISM; GENETICS;

ADULT; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; POLYMORPHISM, GENETIC; PSORIASIS;

EID: 84899478537     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12306     Document Type: Article

References (24)

1. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004; 30: 13-19.
2. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006; 64: 355-365.
3. Wang Y, Lam KS, Kraegen EW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007; 53: 34-41.
4. Schäffler A, Zeitoun M, Wobser H. Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in Caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases. Cardiovasc Diabetol 2007; 6: 3.
5. Senolt L, Polanská M, Filková M, et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1410-1411.
6. Shibata R, Ouchi N, Kikuchi R, et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011; 219: 811-814.
7. Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010; 88: 29-33.
8. Ismail SA, Mohamed SA. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Br J Dermatol 2012; 167: 436-439.
9. National Cholesterol Education Program (NCEP); Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143-3421.
10. Schäffler A, Neumeier M, Herfarth H, et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96-102.
11. Gerdes S, Mrowietz U. Impact of comorbidities on the management of psoriasis. Curr Probl Dermatol 2009; 38: 21-36.
12. Hida K, Wada J, Zhang H, et al. Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats. J Lipid Res 2000; 41: 1615-1622.
13. Yang R, Xu A, Pray J, et al. Cloning of omentin a new adipocytokine from omental fat tissue in humans. Diabetes 2003; (Suppl 1): A1.
14. de Souza Batista CM, Yang RZ, Lee MJ, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56: 1655-1661.
15. Tan BK, Adya R, Farhatullah S, et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008; 57: 801-808.
16. Zhong X, Li X, Liu F, et al. Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochem Biophys Res Commun 2012; 425: 401-406.
17. Kwak JH, Jung JK, Lee H. Nuclear factor-kappa B inhibitors; a patent review (2006-2010). Expert Opin Ther Pat 2011; 21: 1897-1910.
18. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866.
19. Doger FK, Dikicioglu E, Ergin F, et al. Nature of cell kinetics in psoriatic epidermis. J Cutan Pathol 2007; 34: 257-263.
20. Marchetti S, Gamas P, Belhacène N, et al. The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice. EMBO J 2009; 28: 2449-2460.
21. Lizzul PF, Aphale A, Malaviya R. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept. J Invest Dermatol 2005; 124: 1275-1283.
22. Bekris LM, Shephard C, Peterson M, et al. Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 2005; 38: 567-575.
23. Lee SG, Joo Y, Kim B, et al. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 2005; 116: 319-328.
24. Cataño HC, Cueva JL, Cardenas AM, et al. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population. Environ Mol Mutagen 2006; 47: 699-706.